Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117230 | SCV000151403 | benign | not specified | 2013-03-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000117230 | SCV000168822 | benign | not specified | 2014-05-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000117230 | SCV000305105 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000391875 | SCV000376710 | benign | Maturity-onset diabetes of the young type 3 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Personalized Diabetes Medicine Program, |
RCV000445439 | SCV000537086 | benign | Monogenic diabetes | 2019-02-01 | criteria provided, single submitter | research | ACMG criteria: BA1 (overall MAF in gnomAD 3%, 6.6% in South Asian in gnomAD, ~3% in other subpop), BS2 (346 cases and 404 controls in T2DM ) [Revel score 0.597, PP3 (6), BP4 (4)= conflicting evidence, not using] [not using BP6]: benign |
Eurofins Ntd Llc |
RCV000117230 | SCV000707747 | benign | not specified | 2017-04-26 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000713791 | SCV000844423 | benign | not provided | 2017-08-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000713791 | SCV001726692 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002226424 | SCV002505383 | benign | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in this gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. Good response to sulfonylureas. However, rs1800574 localized in the DNA-binding domain of the HNF1A gene (p.Ala98Val) doesn't directly predispose to early-onset Diabetes Mellitus even if the prevalence of the variant is high. | |
Ambry Genetics | RCV002226424 | SCV002747827 | likely benign | Maturity onset diabetes mellitus in young | 2018-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003153378 | SCV003843348 | benign | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315672 | SCV004015761 | benign | Nonpapillary renal cell carcinoma | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000713791 | SCV005234392 | benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000117230 | SCV000085359 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Laboratory of Diagnostic Genome Analysis, |
RCV000117230 | SCV001798964 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000117230 | SCV001929653 | benign | not specified | no assertion criteria provided | clinical testing |